………. but don’t let pain or stiffness from osteoarthritis of the knees hinder your progress.

Two capsules each day of Albert Moon’s Extreme Curcumin with Boswelia is an awful lot of antiinflammatory action and in a short time may free you from the pain and stiffness commonly associated with osteoarthritis, especially of the knees, hips, wrists, and elbows.

“Hi there Kaye,
You may remember I ordered your turmeric caps, several months ago. Well I have something to share with you. I have an unexpected bonus. For seven years I have had bursitis in my hip, I have tried everything, supplements, fish oil, physio, massage, laser etc., but I am now pain free!!! It has to be the turmeric; I have done nothing else different. It took about 1 month, and all of a sudden, one morning I realised the pain was gone. I am over the moon, and I only take 2 per night, before dinner, (and half the time I forget, and take it later). I have googled it, and found it is a potent anti-inflammatory* supplement.
Thank you very much.
I am very surprised, and happy.
Best regards, * Raelene W.
* Individual results may vary.

Dear Kaye
I have been taking your Turmeric & Piperine product for some years.
The pain and inflammation in my knees has gone! Disappeared!
Also giving two a day to my Kelpie dog and he is very happy.
Thank you Kaye.
* Ken C

Also…………

Kaye,
I was recommended by a nurse who was giving up nursing because of painful feet.
Now she is recommending your Curcumin product for backs, shoulders, etc., and
her feet are no longer painful, and she is still working.
Well done.
*Nicholas P.

Also…………….

Kaye,
I can’t believe how quickly it worked!
*Bruce S.

Editor’s Note:- This customer took our Wild Celery Product and our
Curcumin Product both at the same time.

Why our pre-occupation with Piperine? By combining Curcumin with the right quantity of Piperine (from Black Pepper) the Curcumin, which normally has low gastric bio-availability, becomes extremely bioavailable. But 2mg or even 10 mg of Piperine is not enough. 50 mg is enough, so don’t be tempted by price alone.

Why combine Curcumin with Boswelia? Boswelia is a non-toxic gum resin extracted from a tree. The Indians burn it as incense known as Frankincense, as an aromatic, and as an anti-inflammatory medicine. It contains no less than 12 different Boswellic acids. Because the acid AKBA is the most important we concentrate it to a minimum 10%. It has most usage for medicine in Ayurvedic medicine, but is frequently found in Traditional Chinese Medicine, and its usage extends to the Middle East and other tropical regions. Unlike many pharmaceutical medicines both Curcumin and Boswelia have been used for many hundreds of years and have no known short or long-term side effects.

For Rheumatoid arthritis, or Lupus, or Ross River Fever, we heartily recommend our Wild Celery Seed Extracthttps://albertmoons.com.au/index.php/celery-seed , but for Osteoarthritis especially of the knees, hips, elbows, wrists and hands, it may be hard to go past Albert Moon’s Extreme Curcumin plus Boswelia for Osteo.

Studies show that Curcumin capsules as strong as this may lower fasting blood glucose levels of Diabetics, so adjustment of medications may be necessary (see your doctor). Non-Diabetics will not be affected.

Now read these Pubmed Research Articles for yourself and then take action now:

————————————————————————————————————-

Reflections about Osteoarthritis and Curcuma Longa.

Abstract
Osteoarthritis (OA) is a chronic inflammatory degenerative process that affects joints such as the hands, hips, shoulders, feet, spine, and especially knees in millions of people worldwide. Some authors have shown that Curcuma longa components may exhibit benefic effects in the treatment of degenerative diseases as OA. This plant belongs to the family Zingiberaceae and it is popularly known as turmeric or saffron. This review intended to perform a retrospective search to identify studies involving humans and animal models. This review was based on articles linking Osteo Arthritis and Curcuma longa. Databases as Medline, Science Direct, and Lilacs were consulted and a retrospective search was carried out in order to identify studies involving humans and animal models. The curcuminoids from C. longa exhibit actions at different locations in the pathogenesis of OA once it may play an important role as anti-inflammatory, down-regulating enzymes as phospholipase A2, cyclooxygenase-2, and lipoxygenases, and reducing tumour necrosis factor-alpha-and interleukins such as interleukin-1β (IL-1β), IL-6, and IL-8. They also act as inducer of apoptosis in synoviocytes, decreasing the inflammation process and may also reduce the synthesis of reactive oxygen species. For these reasons, new pharmaceutical technology and pharmacological studies should be proposed to determine the dose, the best delivery vehicle, pharmaceutical formulation and route of administration of this plant so its use as an adjunct in the treatment of OA may become a reality in clinical practice. KEYWORDS: Curcuma longa; curcumin; inflammation; osteoarthritis
PMID: 24998034

The spice for joint inflammation: antiinflammatory role of curcumin in treating osteoarthritis.

Abstract
Osteoarthritis is a degenerative disease of the joint affecting aging populations worldwide. It has an underlying inflammatory cause, which contributes to the loss of chondrocytes, leading to diminished cartilage layer at the affected joints.Compounds with anti-inflammatory properties are potential treatment agents for osteoarthritis. Curcumin derived from Curcuma species is an anti-inflammatory compound as such.This review aims to summarize the antiosteoarthritic effects of curcumin derived from clinical and preclinical studies. Many clinical trials have been conducted to determine the effectiveness of curcumin in osteoarthritic patients. Extracts of Curcuma species,curcuminoids and enhanced curcumin, were used in these studies.Patients with osteoarthritis showed improvement in pain, physical function, and quality of life after taking curcumin. They also reported reduced concomitant usage of analgesics and side effects during treatment.In vitro studies demonstrated that curcumin could prevent the apoptosis of chondrocytes,suppress the release of proteoglycans and metal metalloproteases and expression of cyclooxygenase, prostaglandin E-2, and inflammatory cytokines in chondrocytes. These were achieved by blocking the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) system in the chondrocytes, by preventing the activation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha, phosphorylation, and translocation of the p65 subunit of NF-κB complexes into the nucleus. In conclusion,curcumin is a potential candidate for the treatment of osteoarthritis. More well-planned randomized control trials and enhanced curcumin formulation are required to justify the use of curcumin in treating osteoarthritis.KEYWORDS: Curcuma; cartilage; chondrocyte; inflammation; joint; pain
PMID: 24998034

Boswellic acids in chronic inflammatory diseases.

Abstract
Oleogum resins from BOSWELLIA species are used in traditional medicine in India and African countries for the treatment of a variety of diseases. Animal experiments showed antiinflammatory activity of the extract. The mechanism of this action is due to some Boswellic acids. It is different from that of NSAID and is related to components of the immune system. The most evident action is the inhibition of 5-lipoxygenase. However, other factors such as cytokines (interleukins and TNF-alpha) and the complement system are also candidates.Moreover, leukocyte elastase and oxygen radicals are targets. Clinical studies, so far with pilot character, suggest efficacy in some autoimmune diseases including rheumatoid arthritis,Crohn’s disease, ulcerative colitis and bronchial asthma. Side effects are not severe when compared to modern drugs used for the treatment of these diseases.PMID: 17024588

————————————————————————————————————–

Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials.

Abstract
Curcuminoids have received considerable attention as therapeutical adjuvants in the treatment of dysglycemia. The purpose of this meta-analysis was to evaluate whether the supplementation of turmeric extract, curcuminoids and/or isolated curcumin is more effective than placebo in decreasing fasting blood glucose (FBG) in adults. MEDLINE, CENTRAL, ScienceDirect and gray literature databases were searched. Randomized controlled trials with the following criteria were included: (1) studied individuals older than 18 years, supplemented with curcumin, curcuminoids and/or turmeric extract (2) had a follow-up ≥4 weeks (3) used a placebo group. Titles and abstracts were screened and potentially eligible articles were retrieved. The primary outcome was Fasting Blood Glucose. The secondary outcomes were HbA1c and HOMA-IR. Eleven studies were included. In the overall analysis, turmeric, curcuminoids and curcumin supplementation led to a decrease in Fasting Blood Glucose (-8.88, 95% CI: [-5.04 to -2.72] mg/dL, p=0.005). Supplementation of curcuminoids and/or curcumin decreased the concentrations of HbA1c (-0.54, 95% CI: [-1.09 to -0.002] %, p=0.049) but were not able to decrease HOMA-IR (-1.26, 95% CI: [-3.71 to -1.19], p=0.31). Sensitivity analyses revealed that baseline Fasting Blood Glucose was an important covariate. Heterogeneity was high in the overall analyses and there was evidence of publication bias. Supplementation of isolated curcumin or combined curcuminoids were both effective in lowering the Fasting Blood Glucose concentrations of individuals with some degree of dysglycemia, but not in non-diabetic individuals. Isolated curcumin lead to significant decreases of the HbA1ccompared to placebo.